Short Interest in Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) Decreases By 80.0%

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBYGet Free Report) was the recipient of a large drop in short interest in September. As of September 15th, there was short interest totaling 100 shares, a drop of 80.0% from the August 31st total of 500 shares. Based on an average daily volume of 6,200 shares, the days-to-cover ratio is presently 0.0 days. Based on an average daily volume of 6,200 shares, the days-to-cover ratio is presently 0.0 days.

Ambu A/S Trading Down 4.8%

Ambu A/S stock opened at $14.61 on Thursday. The stock has a market cap of $3.43 billion, a PE ratio of 76.89 and a beta of 0.83. The stock has a 50-day moving average price of $15.05 and a 200 day moving average price of $15.72. Ambu A/S has a 52 week low of $13.02 and a 52 week high of $20.24. The company has a current ratio of 2.90, a quick ratio of 1.73 and a debt-to-equity ratio of 0.08.

Ambu A/S (OTCMKTS:AMBBYGet Free Report) last posted its quarterly earnings data on Friday, August 22nd. The company reported $0.07 EPS for the quarter. The firm had revenue of $229.16 million during the quarter. Ambu A/S had a return on equity of 6.11% and a net margin of 5.93%.

About Ambu A/S

(Get Free Report)

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.

Featured Articles

Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.